SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LemonHead who wrote (818)6/4/1999 8:46:00 AM
From: yosi s  Read Replies (1) of 1386
 
I would like to point out one thing.
Pharmos is about to become a + cash flow biotech. This was said by management for the past year.
Target is end of Q4 this year. I will give then an extra Q.
So yes companies raise money in the market in order to grow.
That is what the capital market is all about.
You raise money by issuing shares.
Bonds. etc.
If you are looking at a mature company and they suddenly need money, then you ask what is going on.
Here the company entered a new phase that of generating cash, this is since the launch of Alrex and Lotemax.
Even Microsoft was not a billions revenue when it started.

Pharmos got
1. Product on market
2. products just about ready to go to market
3. expanding markets.
4. Blockbuster ready to enter phase 3.
5. Blockbuster ready to enter phase 1.
6. blockbuster in preclinical.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News